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Abstract
Purpose To analyse costs related to the diagnosis and treatment of patients with sialolithiasis and sialadenitis managed 
with sialendoscopy, and to prospectively evaluate the impact of sialendoscopy on health-related quality of life (HRQoL) in 
a longitudinal follow-up study.
Methods All patients undergoing sialendoscopy or sialendoscopy-assisted surgery at a tertiary care university hospital 
between January 2014 and May 2016 were identified from a surgical database, and the direct hospital costs were retrospec-
tively evaluated from 1 year before to 1 year after the sialendoscopy. The 15D HRQoL questionnaire and a questionnaire 
exploring the use of health care services during the preceding 3 months were mailed to the patients before sialendoscopy as 
well as at 3 and 12 months after the operation.
Results A total of 260 patients were identified. Mean total hospital costs, costs related to the sialendoscopy, and complica-
tions were significantly higher in sialolithiasis patients than in patients with other diagnoses. 74 patients returned the baseline 
15D questionnaire, and 51 patients all three 15D questionnaires. At baseline, the dimensions “discomfort and symptoms” 
and “distress” were lower in patients than in age- and gender-standardised general population, but the total 15D score did not 
differ significantly. The dimension “discomfort and symptoms” improved significantly at 3 and 12 months postoperatively, 
and the mean total HRQoL score improved in patients with sialolithiasis at 3 months postoperatively.
Conclusions The costs related to sialendoscopy are substantial and the cost-effectiveness of sialendoscopy warrants fur-
ther studies. However, sialendoscopy seems to reduce patients’ discomfort and ailments and to improve HRQoL at least in 
patients with sialolithiasis.
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Introduction
The development of sialendoscopy has offered a minimally 
invasive alternative to diagnose and treat obstructive sialad-
enitis. This has led to gland-preserving salivary gland sur-
gery and reduced the need for salivary gland excisions [1]. 
Although designed for the treatment of sialoliths, sialen-
doscopy is currently used also to manage non-stone-related 
obstructive sialadenitis and inflammatory conditions [2–6].
The most common symptom of obstructive sialadenitis 
is recurrent, usually painful swelling of the salivary gland 
during meals, while chronic inflammatory disorders such as 
Sjögren’s syndrome, chronic recurrent parotitis, and juvenile 
parotitis are more often characterized by intermittent, mildly 
tender swelling of the gland(s) that sometimes persists for 
days [7, 8]. Both disorders may be complicated by bacterial 
infections [8]. While the therapeutic benefits of sialendos-
copy have been demonstrated in many studies and reviews 
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[9–11], the effects of sialadenitis and sialendoscopic inter-
vention on patients’ health-related quality of life (HRQoL) 
have been investigated less often. Also, the costs related to 
the treatment of these patients and to sialendoscopy have not 
been comprehensively explored.
The effectiveness of treatment can be measured by 
evaluating the frequency and severity of the disease and by 
recording the pre- and postoperative symptoms. In addition, 
assessment of the HRQoL has gained growing interest dur-
ing the preceding decade. According to the World Health 
Organization, the instrument assessing HRQoL must contain 
at least physical, mental, and social aspects [12]. Because 
there is no gold standard for assessing otorhinolaryngologi-
cal patients’ HRQoL, it remains a challenge to choose a 
proper questionnaire to reflect patients’ QoL.
We designed an observational study to evaluate the health 
care costs and direct hospital costs as well as HRQoL of 
patients treated with sialendoscopy. For the assessment of 
HRQoL, we used the generic, self-administered 15D ques-
tionnaire, which has been shown to be sensitive in detecting 
changes in many patient groups and allows comparison of 
treatment effectiveness across different disorders [13].
Materials and methods
Between January 2014 and May 2016, altogether 260 
patients underwent sialendoscopy or sialendoscopy-assisted 
operation at the Department of Otorhinolaryngology—Head 
and Neck Surgery, Helsinki University Hospital (HUH), 
Helsinki, Finland. The indications for the intervention were 
recurrent swelling or pain of a major salivary gland(s). All 
patients were treated endoscopically or with endoscopy-
assisted combined techniques with direct transoral or trans-
facial sialolith removal usually under local anaesthesia as 
a day surgery. We did not use balloon dilators, lasers, or 
intraductal stonebreakers.
In all, 188 out of 260 patients were preoperatively invited 
by mail to participate in a follow-up questionnaire study 
related to HRQoL and use of health care services. Patients 
under 15 years of age (n = 9) and patients with insufficient 
Finnish or Swedish language skills (n = 20) were excluded. 
Also, some patients were not reached preoperatively mainly 
because of changed operation schedules and, in few cases, 
because of missing contact information (n = 43). Follow-
up questionnaires were sent at 3 and 12 months after the 
operation to those patients who had returned the first ques-
tionnaire. If the follow-up questionnaires were not returned, 
a reminder and a new questionnaire were sent once. Four 
patients who underwent subsequent sialadenectomy were 
excluded from the follow-up.
The study protocol was approved by the Research Ethics 
Committee of Helsinki University Hospital.
Costs
Direct hospital costs were evaluated for all 260 patients 
for the period from 1 year before to 1 year after the sialen-
doscopy. The costs were obtained from the clinical patient 
administration system (Ecomed, Datawell Ltd., Finland), 
which routinely stores all costs of hospital care for each 
patient treated at Helsinki University Hospital. We col-
lected all costs for each patient related to the diagnos-
tics and treatment of salivary gland disease, including 
outpatient and emergency department visits, phone calls, 
pathology examinations, imaging and laboratory ser-
vices, operations, inpatient care, and any complications 
of sialendoscopy.
To assess the self-reported costs of health care services 
related to patients’ salivary gland disorders, we used a 
specifically designed questionnaire in which patients 
evaluated the number of doctor or nurse appointments, 
phone calls, and laboratory services conducted in public 
or private health care as well as inpatient treatments and 
the number of sick-leave days due to salivary gland dis-
order during the preceding 3 months. Use of services and 
duration of sick leave were converted to monetary units 
based on the most recent Finnish data on standard unit 
costs from 2011 [14].
15D
To assess HRQoL, we used the 15D, which is a 15-dimen-
sional, generic, comprehensive, standardised, and self-
administered HRQoL instrument that can be used both 
as a profile and as a single index score measure (http://
www.15d-instr ument .net/15d) [13]. The 15D consists of 
the following 15 dimensions: moving, seeing, hearing, 
breathing, sleeping, eating, speaking, excretion, usual 
activities, mental functioning, discomfort and symptoms, 
depression, distress, vitality, and sexual activity. For each 
of these dimensions, the respondent chooses from among 
five scores the one best describing his/her current state 
of health (best score = 1; worst score = 5). Valuation of 
the 15D is based on the application of the multiple-attrib-
ute utility theory, where a utility or preference weight is 
obtained from the general public through a three-stage 
valuation procedure and used to generate the utility score, 
i.e., the 15D score, which is a single index score. The 
maximum score is 1 (no problems on any dimension) 
and the minimum score 0 (equivalent to being dead). The 
minimal clinically important change or difference in the 
15D has been estimated to be ± 0.015 [15]. The 15D has 
been shown to be highly reliable and responsive to change, 
comparing favourably with other similar instruments 
235European Archives of Oto-Rhino-Laryngology (2019) 276:233–241 
1 3
[13, 16–18]. Patients’ HRQoL was compared at baseline 
with that of the general population. The 15D data for the 
general Finnish population were obtained from the large 
Health 2011 Health Examination Survey [19]. For compar-
ison with the patients of this study, participants from the 
Helsinki and Uusimaa stratum of the Health 2011 survey 
were selected who were in the age range of the patients. 
This subsample (n = 1339) was weighted to reflect the age 
and gender distribution of the patients.
Statistical analysis
Data were analysed with SPSS version 22 (SPSS Inc., 
Chicago, IL, USA). Categorical variables are reported as 
frequencies and percentages, and continuous variables as 
means (standard deviation, SD). Differences between the 
groups regarding age, and operation time were tested with 
one-way Anova with Bonferroni correction and regarding 
gender, gland, and diagnosis with Pearson Chi-Squared test. 
The significance of the difference in the mean 15D score and 
costs between different groups was analysed with independ-
ent samples t test, and the significance between baseline and 
follow-up 15D scores and costs with paired samples t test. P 
values < 0.05 were considered significant.
Results
Hospital costs were calculated for the whole patient series 
(n = 260), which had a mean age of 46 years (SD 17.2, range 
3.6 to 86.1). The postoperative diagnosis was chronic sialad-
enitis in 50%, sialolithiasis in 43%, stenosis/stricture of the 
main duct in 7.3%, and sialosis in 0.4% of patients. Thir-
teen patients underwent sialendoscopy twice, four patients 
underwent submandibulectomy, and two patients underwent 
sublingual gland excision during the study period. Patient 
demographics and characteristics are shown in Table 1.
The 15D questionnaire and the questionnaire concern-
ing self-reported use of health care services were sent to 
188 patients. At baseline, 74 patients (39%), at 3 months 
60 patients (32%), and at 12 months 56 patients (30%) 
returned the questionnaires. All three 15D questionnaires 
were returned by 51 patients (27%). Patient characteristics 
and demographics are shown in Table 1. The respondents 
and non-respondents did not differ significantly regarding 
mean age, gender, operated gland, postoperative diagnosis, 
or operation time.
Costs
During the two-year time period, the total hospital costs 
were 2265 € per patient (SD 968 €, range 1280 to 7880 €), 
the costs of the sialendoscopic procedure(s) were 1673 € 
per patient (SD 466 €, range 1170–4373 €; 1593 € per pro-
cedure), and the costs of clinical encounters (including also 
costs related to phone contacts, laboratory, and imaging) 
were 416 € per patient (SD 378 €, range 0–2215 €). Both 
mean total hospital costs and mean costs of the operation 
were significantly higher in patients with sialoliths than 
in patients with other postoperative diagnoses (p = 0.014 
and p < 0.001, respectively), while the mean costs of clini-
cal encounters were significantly higher in patients with-
out sialoliths (p = 0.012). The mean total hospital costs did 
not differ significantly between the patients with parotid 
Table 1  Patient demographics and characteristics
All patients, n = 260 Patients with pre-
operative 15D data, 
n = 74
Patients with 
complete 15D data, 
n = 51
Patients with complete answers concern-
ing the use of health care services, n = 43
Sex, n (%)
Female 171 (66) 53 (72) 38 (75) 32 (74)
Male 89 (34) 21 (28) 13 (25) 11 (26)
Age, mean, years (SD) 46 (17.2) 51 (16.0) 53 (15.5) 53 (15.0)
Gland, n (%)
Parotid gland 114 (44) 34 (46) 30 (59) 25 (58)
Submandibular gland 146 (56) 40 (54) 21 (41) 18 (42)
Bilateral sialendoscopy, n (%) 18 (6.9) 7 (9.5) 7 (14) 6 (14)
Diagnosis, n (%)
Sialolithiasis 111 (43) 30 (41) 16 (31) 14 (33)
Sialadenitis 129 (50) 39 (53) 31 (61) 25 (58)
Duct stenosis/stricture 19 (7.3) 5 (6.8) 4 (7.8) 4 (9.3)
Sialosis 1 (0.4) 0 (0) 0 (0) 0 (0)
Operation time, mean, min (SD) 36 (27) 35 (26) 37 (29) 39 (31)
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problems and those with submandibular problems, but mean 
costs of the sialendoscopy were significantly higher in sub-
mandibular patients (p = 0.006) and mean costs of clinical 
encounters were higher in patients with parotid problems 
(p = 0.006). Patients’ age or gender did not affect the hos-
pital costs. Complications causing direct hospital costs 
occurred in 21 cases. The mean cost per complication was 
significantly (p = 0.029) higher in patients with sialolithi-
asis (n = 16, 1131 €, SD 1444 €, range 110–4425 €) than in 
patients with other diagnoses (n = 5, 255 €, SD 130 €, range 
110–435 €). The mean hospital costs are presented in Fig. 1.
Forty-three patients (23%) answered all three question-
naires concerning the use of primary health care services 
related to salivary gland disease during the preceding 
3 months. The mean self-reported total costs of health care 
services and the productivity costs of sick leave were 345 € 
(SD 514 €) at baseline (during 3 months before sialendos-
copy), 467 € (SD 1303 €) at 0–3 months postoperatively, and 
72 € (SD 197 €) at 9–12 months postoperatively. The costs 
of the sialendoscopy are not included. A significant decrease 
in the mean total costs occurred from baseline to 12 months 
(p = 0.001). The costs of doctor visits in private or public 
primary health care, hospital costs, and costs of other con-
tacts decreased significantly from baseline to 12 months 
postoperatively (p < 0.01) (Fig. 2).
15D
At baseline, the mean total HRQoL score of the 74 patients 
(0.909, SD 0.079) was clinically importantly lower than 
that of the age- and gender-standardised general population 
(0.925, SD 0.025), but the difference was not statistically 
significant (p = 0.100). Of the individual 15D dimensions, 
the study cohort was significantly worse off than the general 
population on the dimensions of “discomfort and symptoms” 
(p = 0.002) and “distress” (p = 0.032) (Fig. 3).
Among the 51 patients who returned all three HRQoL 
questionnaires, a significant improvement was seen in the 
dimension of “discomfort and symptoms” at 3  months 
(p = 0.014) and at 12 months (p = 0.039) postoperatively, 
but not in the other dimensions or in the mean total HRQoL 
score (Fig. 4). The mean total HRQoL score did not dif-
fer significantly between parotid and submandibular gland 
patients or between diagnostic groups at any time point, but 
it was significantly improved in patients with sialolithiasis 
at 3 months postoperatively (p = 0.015). The mean scores of 
the dimension of “discomfort and symptoms” were signifi-
cantly higher at 3 and 12 months postoperatively in subman-
dibular gland patients (p = 0.022 and p = 0.021, respectively) 
than in parotid gland patients. The patients with sialolithi-
asis had significantly higher mean scores on the dimen-
sions of “depression” and “distress” at baseline (p = 0.013 
and p = 0.035, respectively) and on the dimensions of 
“discomfort and symptoms” (p = 0.046), “depression” 
(p = 0.002), and “distress” (p = 0.006) at 3 months postop-
eratively than patients with other diagnoses.
Discussion
As new treatment methods are developed, it is important to 
evaluate their costs and value for HRQoL. This study investi-
gated the costs of treatment of sialadenitis patients managed 
with sialendoscopy and measured the effect of sialendoscopy 
on patients’ HRQoL using the generic 15D questionnaire at 
a tertiary care academic hospital. This technique has been 
part of our management protocol for salivary gland disorders 
since 2005. Sialendoscopy comprised a substantial part of 
the total hospital costs of the treated patients. Both the mean 
total hospital costs and the mean sialendoscopy costs were 
higher in patients with sialolithiasis, while the mean costs of 
clinical encounters were higher in patients without sialoliths. 
Sialolithiasis patients more often needed general anaes-
thesia, overnight stay in hospital, or a second endoscopic 
procedure to ensure a successful stone removal, explaining 
the higher costs. Also, a higher rate of complications was 
encountered in these patients, which is in line with our ear-
lier results [20]. The higher costs of clinical encounters in 
patients without sialoliths as well as in patients with parotid 
gland problems might be related to the over-representation 
of chronic sialadenitis in these patients with ongoing symp-
toms requiring ambulatory interventions such as intraductal 
saline or cortisone irrigations.
To our knowledge, there are no previous studies investi-
gating the treatment costs in different diagnostic groups or 
between parotid and submandibular glands, and only few 
studies have evaluated the costs of sialendoscopy. Rosbe 
et al. [21] compared the average costs of care of patients 
with juvenile recurrent parotitis treated with sialendoscopy 
relative to those treated conservatively. The average costs 
in the sialendoscopy group were much higher ($31 338 per 
patient vs. $698 per patient), although the treatment out-
comes did not differ significantly. However, the patients 
were not randomized and the sialendoscopy patients had a 
higher frequency and severity of symptoms, hindering com-
parison. Ong et al. [22] estimated the cost-effectiveness of 
transfacial sialendoscopy-assisted removal of parotid sialo-
liths by comparing it with the traditional parotidectomy per-
formed for chronic parotitis. Complete or partial resolution 
of symptoms was noted in 87% of patients after transfacial 
resection and this procedure was less expensive ($22,482 vs. 
$30,546) and faster than parotidectomy. In our study, four 
patients underwent submandibulectomy with mean costs of 
2293 € (not including the diagnostic costs and costs of clini-
cal encounters) indicating that sialendoscopy (1673 €) is a 
more economical procedure in most cases if successful. In 
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Fig. 1  Differences in mean hospital costs during the two-year follow-up according to diagnosis (a) and treated salivary gland (b)
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addition, according to current knowledge a minimally inva-
sive treatment of the obstruction is recommended as recov-
ery of secretory function is reached in most cases [23, 24].
Shashinder et al. [25] evaluated the average costs of 
transoral stone removal in their institution (£197) and 
deduced that this method is the most cost-effective relative 
to the sialendoscopy or gland resection. Their success rate 
for stone removal was 88% and improved over time. In our 
department, the average costs of transoral stone removal 
range from 330 to 1500 € depending on, e.g., the place of 
the procedure (outpatient department or operation thea-
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Fig. 3  The mean 15D profile of patients (n = 74, mean age 51 years, 72% females) before sialendoscopy relative to that of the general population 
standardised for age and gender
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recommendable in ambulatory cases where the stone is 
palpable and distally located. Recently, Kowalczyk et al. 
[26] showed in a cost-effectiveness analysis based on a 
literature review that the upfront sialendoscopy is a more 
cost-effective treatment in radioiodine-induced sialadenitis 
than medical management utilizing ultrasound when the 
willingness-to-pay threshold is $50 000.
However, when assessing the cost-effectiveness of 
sialendoscopy or any other treatment, it is important to 
observe its possible effects on patients’ HRQoL. Patients’ 
and doctors’ perceptions of outcome might differ mark-
edly, and the conception of HRQoL is highly individual-
istic. Moreover, sialendoscopy serves both as a diagnostic 
tool and a treatment method, usually simultaneously.
To date, no validated instrument exists for capturing 
salivary gland-specific HRQoL. Few studies have used 
generic instruments to assess the HRQoL of patients 
treated with sialedoscopy. Kroll et  al. [27] evaluated 
patients’ HRQoL after sialendoscopy using the Short-
Form-36 Health Survey (SF-36). In all, 80–85% of 
patients reported an improvement of symptoms, but still 
the patients showed worse values than the reference group 
in vitality and mental health. No pre-operative assessment 
was obtained. Two different studies have used the Glas-
gow Benefit Inventory (GBI) survey to assess possible 
improvement of patients` HRQoL after sialendoscopy. A 
positive effect was noted in both studies, comparing well 
with other otorhinolaryngological procedures where the 
GBI has been reported [28, 29]. Meier et al. [29] showed 
that the presence of stones as well as the examination of 
the parotid gland had a significant positive impact on GBI 
score.
The generic 15D instrument has been used to measure 
HRQoL among other benign otolaryngological condi-
tions, such as juvenile recurrent respiratory papillomato-
sis, tonsillectomy, and septoplasty, as well as many other 
diseases [30–33]. In our study, the overall mean HRQoL 
score was clinically but not statistically significantly lower 
than in the age- and gender-standardised general popula-
tion at baseline and had increased statistically significantly 
only in patients with sialolithiasis at the 3-month follow-up. 
However, sialendoscopy seems to reduce patients’ ailments 
since the score of the dimension “discomfort and symp-
toms” improved significantly after sialendoscopy in the 
whole patient population. The subgroup analysis revealed 
that ailments in sialolithiasis patients may be less burden-
some and the sialendoscopy more effective than in patients 
with non-sialolith aetiology, while the patients with parotid 
problems might have more often ongoing symptoms after 
sialendoscopy compared to submandibular patients.
Efforts to construct a salivary gland-specific HRQoL 
instrument have been undertaken during the last years. In 
2015, Gillespie et al. [34] used an adapted Oral Health 
Impact Profile-14 (OHIP-14) survey to measure patients’ 
salivary gland-related symptoms and HRQoL. Patients with 
sialoliths had significantly better salivary gland-related QoL 
after sialendoscopic-assisted operation than patients with 
non-sialolith aetiology, which is supported by our result. 
However, the retrospective, cross-sectional design of their 


















Baseline        0.912
3 months       0.922
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Baseline vs 3 months 
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Baseline vs 3 months
* p < 0.05
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** p < 0.05
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Fig. 4  The mean 15D profiles of patients (n = 51, mean age 53 years, 75% females) before sialendoscopy and at 3 and 12 months postoperatively
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introduced the Chronic Obstructive Sialadenitis Symptoms 
(COSS) questionnaire to quantify sialadenitis-specific symp-
toms and to assess the impact of sialendoscopy-assisted 
surgery. The COSS survey evaluates the sialadenitis symp-
toms and impact of the symptoms on daily functions and 
emotional well-being, measuring also the HRQoL [35, 36]. 
A prospective study consisting of 39 patients showed that 
patients with sialolithiasis as well as patients with subman-
dibular problems showed a greater COSS score and symp-
tom improvement than patients without sialolithiasis or 
patients with parotid symptoms, in accord with our findings 
[36].
The main limitation of our study was the low patient 
response rate to the questionnaires, which might be related to 
the study design, as patients received the questionnaires by 
mail and were requested to participate only once. This can 
lead to over- or underrepresentation of patients who were 
satisfied and experienced improvement of symptoms. Other 
methods such as electric questionnaires, an opportunity to 
participate in the study in the hospital on the operation day, 
and face to face contacting could have been more efficient. 
Also, the lack of a control group is a limitation. A control 
group could be, for instance, patients treated with transoral 
sialolith removal technique or a group treated conservatively. 
In addition, use of a disease-specific HRQoL measurement 
tool together with a generic one is recommended. Generic 
HRQoL instruments allow comparison to patients with 
other diseases or to the general population, while disease-
specific instruments are more sensitive in detecting changes 
in symptoms as a consequence of treatment [37]. Validation 
of a universal salivary gland-specific HRQoL instrument is 
needed for better comparison between different techniques 
and studies.
Conclusion
The sialendoscopic treatment of patients with sialolithi-
asis was more expensive than the treatment of patients with 
non-sialolith aetiology, while patients with parotid problems 
and patients with non-sialolith aetiology had higher costs of 
clinical encounters. The costs of sialendoscopy comprised 
a substantial portion of the total hospital costs of the treated 
patients during the two-year follow-up, highlighting the 
importance of patient selection. Sialadenitis patients expe-
rienced discomfort and distress more often than the age- 
and gender-standardised general population. Sialendoscopy 
reduced the ailments of the sialadenitis patients, but the 
overall HRQoL improved only in patients with sialolithi-
asis at the 3-month postoperative follow-up. Additional pro-
spective, long-term follow-up trials are warranted to further 
assess the impact of sialendoscopy on the HRQoL as well 
as the cost-effectiveness of sialendoscopy.
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